Many breast cancers depend on hormones including estrogen or progesterone for their survival and proliferation. Eight years of lab work at the University of Colorado Cancer Center and elsewhere suggest that the androgen (AR) ...
Jun 4, 2012
0
0
Older Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in the last weeks of life, according to a study led by investigators at Harvard-affiliated ...
Jan 18, 2023
0
10
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
Apr 10, 2019
0
1
An engineered peptide provides a new prototype for killing an entire category of resistant bacteria by shredding and dissolving their double-layered membranes, which are thought to protect those microbes from antibiotics.
Jan 24, 2013
0
0
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Nov 14, 2011
0
0
Mount Sinai researchers conducting clinical trials of a drug targeting a cancer gene found that it increased metastatic cancer patients' survival and was able to work within the brain, according to a study published in Clinical ...
Feb 10, 2022
0
5
Administering radiation therapy to multiple myeloma patients waiting for CAR T cells to be manufactured was found to be safe and undisruptive to CAR T therapy, according to a new study from researchers in the Abramson Cancer ...
Oct 28, 2020
0
1
The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.
Sep 17, 2012
0
0
A new study links being overweight in middle age and later adulthood to a greater risk of advanced prostate cancer. Jeanine Genkinger, Ph.D., an epidemiologist at Columbia University Mailman School of Public Health, and colleagues ...
Mar 4, 2020
0
2
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy for multiple myeloma, a blood cancer, according to a study ...
Dec 19, 2019
0
1
